Role of brain 2-[ 18 F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis.

Antonio CanosaAlessio MartinoUmberto ManeraRosario VastaMaurizio GrassanoFrancesca PalumboSara CabrasFrancesca Di PedeVincenzo ArenaCristina MogliaAlessandro GiulianiAndrea CalvoAdriano ChiòMarco Pagani

Published in: European journal of nuclear medicine and molecular imaging (2022)

F]FDG-PET represents a promising biomarker for individual patients' stratification in clinical trials. The lack of a multicentre external validation of the model warrants further studies to evaluate its generalization capability.

Keyphrases

positron emission tomography
computed tomography
clinical trial
pet ct
pet imaging
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
type diabetes
multiple sclerosis
blood glucose
adipose tissue
phase iii
glycemic control